ELIFE HLDGS Completes Placement of 271 Million Shares, Raising Net Proceeds of Approximately HK$27.1 Million
Stock News
Apr 29
ELIFE HLDGS (00223) has announced that all conditions under the placement agreement, as amended and supplemented, have been fulfilled. The placement was completed on April 29, 2026. Pursuant to the terms of the agreement, a total of 271 million placement shares, representing approximately 16.67% of the company's total issued share capital as enlarged by the issuance, were successfully placed by the placing agent with no fewer than six placees at a price of HK$0.102 per share. The gross proceeds from the placement amounted to approximately HK$27.7 million. After deducting commissions and other related expenses, the net proceeds are approximately HK$27.1 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.